µ±Ç°Î»Ö㺠Ê×Ò³ > ÕÐÆ¸ÐÅÏ¢ >ËÕÖÝϵͳҽѧÑо¿ËùÇØÏþ·å¿ÎÌâ×éÕÐÆ¸¸±ÑУ¬ÖúÀíÑо¿Ô±¼°¿ÆÑÐÃØÊé

ËÕÖÝϵͳҽѧÑо¿ËùÇØÏþ·å¿ÎÌâ×éÕÐÆ¸¸±ÑУ¬ÖúÀíÑо¿Ô±¼°¿ÆÑÐÃØÊé

×÷Õß Ñó´Ð
À´Ô´: Сľ³æ 350 7 ¾Ù±¨Ìû×Ó
+¹Ø×¢

Ò»¡¢ÕÐÆ¸¸Úλ£ºËÕÖÝϵͳҽѧÑо¿ËùÇØÏþ·å¿ÎÌâ×鸱Ñо¿Ô±/ÖúÀíÑо¿Ô±
ÕÐÆ¸ÈËÊý£º2Ãû
ÈÎÖ°ÒªÇó£º
1.        È¡µÃ¹úÄÚÍâÖªÃû¸ßУ»ò¿ÆÑÐÔºËùÈ«ÈÕÖÆ²©Ê¿Ñ§Î»£¨º¬2017ÄêÓ¦½ì±ÏÒµÉú£©£¬ÒÔµÚÒ»×÷Õß·¢±í¹ýSCIÑо¿ÂÛÎÄ£»
2.        Ö×Áö¡¢Ö×ÁöÃâÒß¼°Ö×ÁöÉúÎïÐÅÏ¢Ïà¹Ø×¨ÒµºÍÑо¿ÁìÓò£»
3.        ÓÐÃâÒßѧ±³¾°£¬Ö×ÁöÒ©ÎïÑз¢ºÍÁÙ´²×ª»¯Ó¦ÓÃÏà¹Ø¾­Ñé¼°¶¯ÎïÄ£ÐÍʵÑé¼¼ÄÜÓÅÏÈ£»
4.        Á¼ºÃµÄÖÐÓ¢ÎÄÌý¡¢ËµºÍд×÷ÄÜÁ¦£¬¾ß±¸¶ÀÁ¢µÄ¿ÆÑÐ̽Ë÷¡¢ÂÛÎÄ׫дºÍ¿ÎÌâÉ걨ÄÜÁ¦£»
5.        ÉíÐĽ¡¿µ£¬¾ß±¸Á¼ºÃµÄÍŶӺÏ×÷ÄÜÁ¦ºÍÒâÔ¸ ¡£
6.        Ö÷ÒªÑо¿·½ÏòÓë¸ÚλְÔð£º
        ¿¹Ö×ÁöÃâÒß»úÖÆ¼°anti-PD1/anti-PD-L1ÃâÒßÖÎÁÆÄÍÊÜÄæ×ªÍ¾¾¶µÄ»ù´¡ºÍת»¯Ó¦ÓÃÑо¿£»
        Äܹ»Ö¸µ¼Ñо¿ÉúºÍ¼¼ÊõÈËÔ±µÄ¿ÎÌ⹤×÷£¬°´Ñо¿Ð¡×é¿ÎÌâ·½Ïò½øÐд´ÐÂÐÔÑо¿£¬¶ÀÁ¢ÉêÇë¼°³Ðµ£Ïà¹ØÑо¿ÁìÓò¸÷¼¶¿ÆÑÐÏîÄ¿£¬Ð­ÖúPI½øÐÐÑо¿³É¹ûµÄ×ܽá»ã±¨ºÍÂÛÎÄ׫д¡£
¹¤×÷µØµã£ºËÕÖݹ¤ÒµÔ°Çø
¹¤×÷´ýÓö£º
1.        ¸±Ñо¿Ô± 20-25W/ÄꣻÖúÀíÑо¿Ô±15-20W/Äꣻ
2.        ¶ÔÓÚÄÜÁ¦Í»³ö¡¢¹¤×÷±íÏÖ³öÉ«Õߣ¬¸ù¾Ý¼¨Ð§·¢·Å¾ßÓоºÕùÁ¦µÄ½±½ðºÍ²¹Öú£»
3.        ЭÖú×â·¿»òÕß°²Åż¯ÌåËÞÉá¡£
ӦƸ·½Ê½£º
ÓÊÏ䵨ַ£ºmengfang1978@foxmail.com
µÝ½»²ÄÁÏ£º¸öÈËÏêϸÖÐÓ¢ÎļòÀú+Ïà¹ØÖ¤Ã÷
ӦƸÁ÷³Ì£º
1.        ¼òÀú³õÉóͨ¹ýÕß½«µç»°Í¨Öª±¾È˲μÓÃæÊÔ£»
2.        ÃæÊÔͨ¹ýºó£¬½«½øÐÐ×ʸñÉó²é£»
3.        ×ʸñÉó²éͨ¹ýºó£¬¹«Ê¾7Ì죻
4.        ¹«Ê¾½áÊøºó°ìÀíÕýʽƸÓÃÊÖÐø£»
5.        ÔñÓżȡ£¬ÕÐÂúΪֹ¡£

¶þ¡¢ÕÐÆ¸¸Úλ£ºËÕÖÝϵͳҽѧÑо¿ËùÇØÏþ·å¿ÎÌâ×é¿ÆÑÐÃØÊé
ÕÐÆ¸ÈËÊý£º1Ãû
ÈÎÖ°ÒªÇó£º
1.        ÉúÃü¿ÆÑ§¡¢Ò½Ñ§»òҩѧרҵ±¾¿Æ»ò˶ʿÑо¿ÉúѧÀú£¬ÓÐʵÑéÊÒ¹ÜÀí¹¤×÷¾­ÑéµÄÓÅÏÈ£»
2.        ÒªÓнϺõķþÎñÒâʶ£»¹¤×÷ϸÖÂÈÏÕæ£¬°ìÊÂÑϽ÷¿É¿¿£»
3.        ÓнÏÇ¿µÄÎÄ×Ö׫д¹¦µ×¡¢¹µÍ¨Ð­µ÷¡¢ÓïÑÔ±í´ïÄÜÁ¦£»
4.        ÉíÐĽ¡¿µ£¬¾ß±¸Á¼ºÃµÄÍŶÓЭ×÷ÄÜÁ¦ºÍÒâÔ¸ ¡£
5.        ÓÅÏÈ¿¼ÂÇÓÐÃâÒßѧ¡¢Ö×Áöѧ¡¢¼ìÑéµÈҽѧ»òÉúÎïÏà¹Ø½ÌÓý±³¾°ºÍ¹¤×÷¾­ÑéµÄÈËÑ¡¡£
¸ÚλְÔð£º
1£®        ЭÖúPI´¦ÀíʵÑéÊÒ½¨Éè¡¢¿ÆÑÐÏîÄ¿¹ÜÀí¡¢ÓëÖ°Äܲ¿ÃŶԽӵÈÈÕ³£ÊÂÎñ£»
2£®        ¸ºÔðʵÑéÊÒ¿ÆÑÐÏà¹ØµÄÉ豸¼°ÊÔ¼ÁºÄ²ÄµÄ¶©¹ºÓëÕËÎñ±¨Ïú£»
3£®        ¸ºÔðʵÑéÊҵĽӴý¡¢Ðû´«ºÍÍâʹ¤×÷£»
4£®        ЭÖú¿ÆÑÐÈËÔ±Íê³É¿ÆÑÐÏîĿԤËã¡¢½áÌâµÈÏà¹ØÊÂÎñ£»
5£®        ¸ºÔðϸ°û¿â¡¢ÖÊÁ£¿âµÈʵÑé²ÄÁϵĹÜÀí¹¤×÷
6£®        ¸ºÔðʵÑéÊÒʵÑé¼¼Êõ·½·¨¡¢¹æ·¶Á÷³Ì£¬ºÏͬ¡¢Ð­ÒéµÈÎÄ×Ö²ÄÁϵÄÕûÀí׫д¼°½¨µµ¹ÜÀí£»
7£®        Íê³ÉPI½»°ìµÄÆäËü¹¤×÷¡£
¹¤×÷´ýÓö£º
¹¤×Ê´ýÓö½«Í³Ò»°´ÕÕËÕÖÝϵͳҽѧÑо¿Ëù¹æ¶¨Ö´ÐУ»
ЭÖú×â·¿»òÕß°²Åż¯ÌåËÞÉ᣻
¶ÔÓÚÄÜÁ¦Í»³ö¡¢¹¤×÷±íÏÖ³öÉ«Õߣ¬¸ù¾Ý¼¨Ð§·¢·Å¾ßÓоºÕùÁ¦µÄ½±½ðºÍ²¹Öú£»
ӦƸ·½Ê½£º
ÓÊÏ䵨ַ£ºmengfang1978@foxmail.com
µÝ½»²ÄÁÏ£º¸öÈËÏêϸÖÐÎļòÀú+Ïà¹ØÖ¤Ã÷
ӦƸÁ÷³Ì£º
£¨1£©¼òÀú³õÉóͨ¹ýÕß½«µç»°Í¨Öª±¾È˲μÓÃæÊÔ£»
£¨2£©ÃæÊÔͨ¹ýºó£¬½«½øÐÐ×ʸñÉó²é£»
£¨3£©×ʸñÉó²éͨ¹ýºó£¬¹«Ê¾7Ì죻
£¨4£©¹«Ê¾½áÊøºó°ìÀíÕýʽƸÓÃÊÖÐø£»
£¨5£©ÔñÓżȡ£¬ÕÐÂúΪֹ¡£

[ À´×Ô°æ¿éȺ ½­ËÕ ] ·µ»ØÐ¡Ä¾³æ²é¿´¸ü¶à

½ñÈÕÈÈÌû
  • ¾«»ªÆÀÂÛ
  • ÎÞ¾Ìlaser

    Õâ¸öµ¥Î»ÊÇɶÀ´Í·°¡£¬ÔõôûÌý˵¹ýÄØ

  • Ñó´Ð

    ÒýÓûØÌû:
    3Â¥: Originally posted by ÎÞ¾Ìlaser at 2017-12-27 11:01:45
    Õâ¸öµ¥Î»ÊÇɶÀ´Í·°¡£¬ÔõôûÌý˵¹ýÄØ

    ÎÒÃÇÊÇÖйúÒ½¿ÆÔºÏÂÊôµÚ19¸öÑо¿Ëù£¬ÔÚËÕÖݹ¤ÒµÔ°Çø£¬Ð´óÂ¥ÒѾ­Âä³É£¬ÈËÔ±¹¹¼ÜÕýÔÚ½øÐС£ÏêÇéÇë¼ûÎÒÃǵÄÑо¿ËùÖ÷Ò³£ºhttps://www.ismsz.cn/¡£

    лл¸÷λµÄ¹Ø×¢£¡

  • Ñó´Ð

    ¼ÌÐøÈÈÕУ¡

  • Ñó´Ð

    ÓÑÇéÌáʾ£º
    ËÕÖÝϵͳҽѧÑо¿ËùÂí·é¿ÎÌâ×éÕÐÊÕ
    ϵͳËù-Î÷½»ÀûÎïÆÖ´óѧÁªºÏÅàÑø²©Ê¿Éú

    ÏîÄ¿Ãû³Æ£º
    The role of long non-coding RNA and RNA m6A methylation in host antiviral immunity

    ÏîÄ¿½éÉÜ£º
    Although extensive evidence has suggested the important roles of lncRNAs and m6A RNA methylation in host-pathogen interactions and host antiviral immunity. However, it is still unclear which lncRNAs broadly or specifically controls host antiviral immunity during viral infection. In addition, it is unknown whether the RNA m6A modifiers also participate in the battle between invading pathogens and host immune systems. In this project, we plan to answer these questions and figure out the detail molecular mechanisms. Based on the studies of the project, we will provide diagnosis and therapy strategies and targets for the infectious diseases.
    ÏêϸÐÅÏ¢²Î¼û£º
    https://www.xjtlu.edu.cn/assets/files/admissions/phd-projects/biosci/FOS-17-15%20XJTLU-SISM%20Joint%20PhD-Rong%20Rong-%20BS.pdf

    ÅàÑøÄ£Ê½£º
    ¸ÃÏîÄ¿Ñ§ÖÆ3-4Äê¡£ÓÉÖйúҽѧ¿ÆÑ§ÔºËÕÖÝϵͳҽѧÑо¿Ëù¡¢Î÷½»ÀûÎïÆÖ´óѧºÍÓ¢¹úÀûÎïÆÖ´óѧÈý·½ÁªºÏµ¼Ê¦¹²Í¬ÅàÑø£¬ÓÉÓ¢¹úÀûÎïÆÖ´óѧ£¨È«ÇòÅÅÃûtop100£©°ä·¢²©Ê¿Ñ§Î»¡£Ñ§ÉúÔÚ¶ÁÆÚ¼äµÄÖ÷ҪѧϰºÍ¿ÆÑй¤×÷¿ªÕ¹Ö÷ÒªµØµãÊÇËÕÖÝϵͳҽѧÑо¿Ëù£¬Í¬Ê±Ò²ÓÐÓлú»áÈ¥Ó¢¹úÀûÎïÆÖ´óѧ¶ÌÆÚ½»Á÷·ÃÎʵĻú»á¡£ÔÚ¶ÁÆÚ¼äÃâÈýÄêѧ·Ñ£¨Ô¼80,000Ôª/Ä꣩£¬¿ÎÌâ×黹½«ÌṩÉú»î²¹Öú£¨3500Ôª/Ô£©£¬ÇҲμӹú¼Ê»áÒéµÄ×î¸ß²¹Ìù¿É´ï16,500Ôª¡£

    µ¼Ê¦ÍŶӣº
            Âí·é ½ÌÊÚ£¬ËÕÖÝϵͳҽѧÑо¿Ëù
    µ¼Ê¦¼ò½é£º
    https://www.ismsz.cn/Index/Page/c7598594-c2d2-446b-913d-82c0edd4e648
            ÈÙÈÙ ½ÌÊÚ£¬Î÷½»ÀûÎïÆÖ´óѧ
    µ¼Ê¦¼ò½é£ºhttps://www.xjtlu.edu.cn/zh/departments/academic-departments/biological-sciences/staff/rong-rong
            Dr Neil Blake ,UoL, Institute of Infection and Global Health
    µ¼Ê¦¼ò½é£º
    https://www.liverpool.ac.uk/infection-and-global-health/staff/neil-blake/

    ÉêÇëÌõ¼þ£º
    1¡¢ÓµÓÐÃâÒßѧ¡¢·Ö×ÓÉúÎïѧ¡¢Ï¸°ûÉúÎïѧ¡¢Î¢ÉúÎïѧ¡¢Ò©Ñ§µÈÏà¹ØÁìÓò˶ʿѧλ£»
    2¡¢Ô­211»ò985´óѧ£¨»òÏÖ¡°Ë«Ò»Á÷¡±´óѧ£©±ÏÒµ£¬±¾¿Æ³É¼¨ÓÅÐã(ƽ¾ù·Ö80ÒÔÉÏ)£»
    3¡¢¾ß±¸Á¼ºÃµÄÓ¢ÎÄÌý¡¢Ëµ¡¢Ð´×÷ÄÜÁ¦£¬ÑÅ˼³É¼¨6.5·Ö¼°ÒÔÉÏ»òÕßiBT³É¼¨88·Ö¼°ÒÔÉÏ£»
    4¡¢µÚÒ»×÷Õß·¢±í¹ýSCI»ò˶ʿ±ÏÒµÉúÓÅÏÈ¿¼ÂÇ£»       

    ÉêÇëÁ÷³Ì£º
    1¡¢ÓÐÒâÕß½«ÒÔϲÄÁÏ·¢ÖÁÓÊÏ䣺feng.ma.sam@gmail.comºÍRong.Rong@xjtlu.edu.cn
            ¼òÀú
            Á½·âÓÉѧУ»ò¹«Ë¾ÌṩµÄÍÆ¼öÐÅ(»òÍÆ¼öÈËÁªÏµ·½Ê½)
            ¹ØÓÚ¸öÈË¿ÆÑÐÐËȤµÄ¸öÈ˳ÂÊö
            Ó¢ÓïÄÜÁ¦Ïà¹ØÖ¤Ã÷£¨ÑÅ˼»òiBT£©
            ÖÐÓ¢ÎÄÔÚУ³É¼¨µ¥
            ѧÀú¡¢Ñ§Î»Ö¤Êé
    2¡¢Í¨¹ý³õÑ¡Õßͳһ°²ÅÅÃæÊÔ£»
    3¡¢ÔñÓżȣ¬

  • 1740OMG

    ÒýÓûØÌû:
    6Â¥: Originally posted by Ñó´Ð at 2018-02-02 10:47:57
    ÓÑÇéÌáʾ£º
    ËÕÖÝϵͳҽѧÑо¿ËùÂí·é¿ÎÌâ×éÕÐÊÕ
    ϵͳËù-Î÷½»ÀûÎïÆÖ´óѧÁªºÏÅàÑø²©Ê¿Éú

    ÏîÄ¿Ãû³Æ£º
    The role of long non-coding RNA and RNA m6A methylation in host antiviral immunity

    ÏîÄ¿½éÉÜ£º
    Alth ...

    ÀÏʦÄúºÃ£¬ÇëÎÊÕâ¸ö²©Ê¿ÉêÇëµÄ½ØÖ¹Ê±¼äÊÇʲôʱºòÄØ£¿ÎÒ¿ÉÄÜÐèҪ׼±¸È¥¿¼ÑÅ˼¿¼ÊÔ¡£

  • Ñó´Ð

    ÒýÓûØÌû:
    7Â¥: Originally posted by 1740OMG at 2018-02-02 20:51:27
    ÀÏʦÄúºÃ£¬ÇëÎÊÕâ¸ö²©Ê¿ÉêÇëµÄ½ØÖ¹Ê±¼äÊÇʲôʱºòÄØ£¿ÎÒ¿ÉÄÜÐèҪ׼±¸È¥¿¼ÑÅ˼¿¼ÊÔ¡£...

    Õâ¸öÏîĿÿÄ꣬¾ßÌ嵼ʦÇëÁªÏµÂí·éÀÏʦfeng.ma.sam@gmail.com£¬Ð»Ð»¹Ø×¢¡£

²ÂÄãϲ»¶
ÏÂÔØÐ¡Ä¾³æAPP
Óë700Íò¿ÆÑдïÈËËæÊ±½»Á÷
  • ¶þάÂë
  • IOS
  • °²×¿